Orthofix International Comments on Competitor's Statements on Investor Call

April 21, 2010

BOSTON, Apr 21, 2010 (BUSINESS WIRE) -- Orthofix International N.V. (NASDAQ:OFIX) (the Company) today responded to public comments made yesterday by NuVasive, Inc. during their first quarter earnings call stating that a dispute has been initiated against the Company. The comments indicated that the dispute apparently concerns the defense of patents acquired by NuVasive.

NuVasive has not been in contact with the Company, nor has the Company received any information from NuVasive regarding the dispute.

"At best, we find both the NuVasive announcement and the forum for the announcement questionable. We prefer to compete in the marketplace so that we can continue to bring next generation technologies to the market for the benefit of patients and surgeons who treat them. It is Orthofix's policy to respect the intellectual property rights of others, and we are prepared to vigorously defend ourselves against any allegations to the contrary," stated Orthofix's CEO, Alan Milinazzo.

About Orthofix International N.V.

Orthofix International N.V., a global medical device company, offers a broad line of minimally invasive surgical, as well as non-surgical, products for the spine, orthopedic, and sports medicine market sectors that address the lifelong bone-and-joint health needs of patients of all ages, helping them achieve a more active and mobile lifestyle. Orthofix's products are widely distributed around the world to orthopedic surgeons, hospitals and patients via Orthofix's sales representatives and its subsidiaries, including Breg, Inc. and Blackstone Medical, Inc. In addition, Orthofix is collaborating in R&D partnerships with leading institutions such as the Musculoskeletal Transplant Foundation, the Orthopedic Research and Education Foundation, the Musculoskeletal Transplant Foundation, and the National Osteoporosis Institute. For more information about Orthofix, please visit www.orthofix.com.

SOURCE: Orthofix International N.V.

Orthofix International N.V.
Dan Yarbrough, 617-912-2903
Vice President of Investor Relations

Copyright Business Wire 2010